.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
QuintilesIMS
Fish and Richardson
McKinsey
Express Scripts
Cerilliant
Merck
US Department of Justice
Colorcon
Accenture

Generated: September 25, 2017

DrugPatentWatch Database Preview

Mallinckrodt Hosp Company Profile

« Back to Dashboard

What is the competitive landscape for MALLINCKRODT HOSP, and when can generic versions of MALLINCKRODT HOSP drugs launch?

MALLINCKRODT HOSP has two approved drugs.

There are seventeen US patents protecting MALLINCKRODT HOSP drugs.

There are twenty-one patent family members on MALLINCKRODT HOSP drugs in nine countries.

Summary for Applicant: Mallinckrodt Hosp

Patents:17
Tradenames:2
Ingredients:2
NDAs:2
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mallinckrodt Hosp
INOMAX
nitric oxide
GAS;INHALATION020845-003Dec 23, 1999RXYesYes► Subscribe► SubscribeY► Subscribe
Mallinckrodt Hosp
INOMAX
nitric oxide
GAS;INHALATION020845-003Dec 23, 1999RXYesYes► Subscribe► SubscribeY► Subscribe
Mallinckrodt Hosp
INOMAX
nitric oxide
GAS;INHALATION020845-002Dec 23, 1999DISCNYesNo► Subscribe► SubscribeY► Subscribe
Mallinckrodt Hosp
INOMAX
nitric oxide
GAS;INHALATION020845-002Dec 23, 1999DISCNYesNo► Subscribe► SubscribeY► Subscribe
Mallinckrodt Hosp
UVADEX
methoxsalen
INJECTABLE;INJECTION020969-001Feb 25, 1999RXYesYes► Subscribe► Subscribe► Subscribe
Mallinckrodt Hosp
INOMAX
nitric oxide
GAS;INHALATION020845-003Dec 23, 1999RXYesYes► Subscribe► SubscribeY► Subscribe
Mallinckrodt Hosp
INOMAX
nitric oxide
GAS;INHALATION020845-003Dec 23, 1999RXYesYes► Subscribe► SubscribeY► Subscribe
Mallinckrodt Hosp
INOMAX
nitric oxide
GAS;INHALATION020845-003Dec 23, 1999RXYesYes► Subscribe► SubscribeY► Subscribe
Mallinckrodt Hosp
INOMAX
nitric oxide
GAS;INHALATION020845-002Dec 23, 1999DISCNYesNo► Subscribe► SubscribeY► Subscribe
Mallinckrodt Hosp
INOMAX
nitric oxide
GAS;INHALATION020845-002Dec 23, 1999DISCNYesNo► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Mallinckrodt Hosp

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mallinckrodt Hosp
INOMAX
nitric oxide
GAS;INHALATION020845-003Dec 23, 1999► Subscribe► Subscribe
Mallinckrodt Hosp
UVADEX
methoxsalen
INJECTABLE;INJECTION020969-001Feb 25, 1999► Subscribe► Subscribe
Mallinckrodt Hosp
INOMAX
nitric oxide
GAS;INHALATION020845-002Dec 23, 1999► Subscribe► Subscribe
Mallinckrodt Hosp
UVADEX
methoxsalen
INJECTABLE;INJECTION020969-001Feb 25, 1999► Subscribe► Subscribe
Mallinckrodt Hosp
INOMAX
nitric oxide
GAS;INHALATION020845-003Dec 23, 1999► Subscribe► Subscribe
Mallinckrodt Hosp
INOMAX
nitric oxide
GAS;INHALATION020845-003Dec 23, 1999► Subscribe► Subscribe
Mallinckrodt Hosp
INOMAX
nitric oxide
GAS;INHALATION020845-002Dec 23, 1999► Subscribe► Subscribe
Mallinckrodt Hosp
INOMAX
nitric oxide
GAS;INHALATION020845-003Dec 23, 1999► Subscribe► Subscribe
Mallinckrodt Hosp
INOMAX
nitric oxide
GAS;INHALATION020845-002Dec 23, 1999► Subscribe► Subscribe
Mallinckrodt Hosp
INOMAX
nitric oxide
GAS;INHALATION020845-002Dec 23, 1999► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for MALLINCKRODT HOSP drugs

Drugname Dosage Strength Tradename Submissiondate
nitric oxide
for Inhalation100 ppm and 800 ppm
INOMAX
5/20/2014

International Patent Family for Mallinckrodt Hosp Drugs

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2015127085► Subscribe
Australia2015200792► Subscribe
Japan2014505536► Subscribe
Canada2779766► Subscribe
Mexico2013007931► Subscribe
New Zealand611564► Subscribe
Mexico2016010359► Subscribe
Japan5923523► Subscribe
World Intellectual Property Organization (WIPO)2012094008► Subscribe
Australia2015218945► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Mallinckrodt Hosp Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB08/019United Kingdom► SubscribePRODUCT NAME: NITRIC OXIDE (NO); REGISTERED: UK EU/1/01/194/001 20010801
02C/003Belgium► SubscribePRODUCT NAME: NITRIC OXIDE; REGISTRATION NO/DATE: EU/1/01/194/001 20010801
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
US Army
Mallinckrodt
Healthtrust
Fuji
UBS
Chubb
Teva
Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot